Cancer Cell International invites you to join our team of reviewers. For consideration, please send your CV to firstname.lastname@example.org.
New reviewer recruitment
Aims and scope
Cancer Cell International publishes articles on all aspects of cancer cell biology, originating largely from, but not limited to, work using cell culture techniques. Read more here.
Spotlight: Associate Editor
Andy Tao Yin Lau
After obtaining his PhD degree (Molecular Biology) at the University of Hong Kong, Dr. Andy Tao Yin Lau joined the University of Minnesota (USA) as a postdoctoral fellow on Cancer and Epigenetics Research. Since 2011, he has been working as a Principal Investigator and established the Laboratory of Cancer Biology and Epigenetics at Shantou University Medical College (P. R. China). Dr. Lau’s research team studies the molecular basis of cancers by using “OMICS” approaches. For example, he has applied proteomic-based platform to study the proteome and epiproteome responses of carcinogen-exposed lung cells/anticancer drug-treated lung cancer cells and the identification of novel biomarker signatures. Moreover, he is interested in functional characterization of novel protein post-translational modifications and their relationship in human diseases including cancers.
Spotlight: Editorial Board
Koraljka Gall Trošelj
Dr. Koraljka Gall Trošelj earned her MD degree at the University of Zagreb (Croatia), from where she received both a Masters and PhD degree in biomedicine – molecular oncology. She is a Fulbright Scholar who spent two years in the US at the Weill Cornell Medical School in New York City. Dr. Gall Trošelj is currently the head of the Laboratory for Epigenomics in the Division of Molecular Medicine at the Rudjer Boskovic Institute, Zagreb, Croatia. Dr. Gall Troselj is particularly interested in modulation of the epigenome by natural compounds, especially curcumin, in the context of chemoprevention. She has developed a fruitful collaboration with Croatian clinicians, especially oncologists, head and neck surgeons and pathologists. Her current national research project, funded by the Croatian Science Foundation (NRF2 at the crossroads of epigenetic remodeling, metabolism and proliferation of cancer cells), is focused on discovering mechanisms of NRF2 and EZH2 interplay in a setting of various kinds of cellular stresses to which cancer cells are or may be exposed.
Annual Journal Metrics
56 days to first decision for reviewed manuscripts only
50 days to first decision for all manuscripts
114 days from submission to acceptance
12 days from acceptance to publication
153 Altmetric mentions
On the blog
30 September 2019
09 September 2019
06 September 2019
Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).